U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020199

Expand all

HIVID (ZALCITABINE)
0.375MG
Marketing Status: Discontinued
Active Ingredient: ZALCITABINE
Proprietary Name: HIVID
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.375MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020199
Product Number: 001
Approval Date: Jun 19, 1992
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
HIVID (ZALCITABINE)
0.75MG
Marketing Status: Discontinued
Active Ingredient: ZALCITABINE
Proprietary Name: HIVID
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.75MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020199
Product Number: 002
Approval Date: Jun 19, 1992
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top